1-4 of 4
José Gómez Codina, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Diffuse Large B Cell Lymphoma Genetic Classification By Targeted Sequencing and Associations with Immunochemotherapy-Treated Patients' Clinical Outcome

Lucia Pedrosa Perez, Ismael Fernández-Miranda, David Perez Callejo, Cristina Quero, Marta Rodriguez, Paloma Martin-Acosta, Sagrario Gomez, Julia González-Rincón, Adrian Santos, Carlos Tarin, Juan F. Garcia, Francisco R García-Arroyo, Antonio Rueda, Francisca I Camacho, Monica Garcia-Cosio, MD, Ana Heredero, Marta Llanos, Manuela Mollejo, Miguel Piris-Villaespesa, José Gómez Codina, MD, Natalia Yanguas-Casás, Antonio Sánchez, Miguel A. Piris, Mariano Provencio, Margarita Sanchez-Beato
Journal: Blood
Blood (2020) 136 (Supplement 1): 24–25.
https://doi.org/10.1182/blood-2020-141193
Published: 2020
Journal Articles

Peripheral T-Cell Lymphomas in Spain: Profiling Clinical, Phenotypic and Genetic Characteristics in Spanish Population

Raul Cordoba, MD PhD, María Socorro Rodriguez-Pinilla, MD, Narvaez Javier, Fina Climent, MD, Joaquin Sanchez, MD, Carlos Perez Seoane, MD, Javier Lopez Jimenez, MD PhD, Monica Garcia Cosio, MD, Dolores Caballero, MD, Óscar Javier Blanco Núñez, MD, Cecilia Carpio, MD, Josep Castellvi, MD, Antonio Martinez Pozo, MD, Ivan Dlouhy, MD, Angeles Bendaña, MD, Carlos Aliste, MD, Ana Julia Gonzalez, MD, María Soledad Fernandez, MD, Sonia González de Villambrosia, MD, Miguel A. Piris, PhD MD, Jose Gomez Codina, MD, Empar Mayordomo, MD, Belén Navarro, MD, Carmen Bellas, MD, Guillermo Rodríguez, MD, Juan José Borrero, MD, Ana Ruiz-Zorrilla, MD, Carmen Montoto, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2938.
https://doi.org/10.1182/blood-2018-99-116562
Published: 2018
Journal Articles

Risk Adapted-High Dose Therapies Modulate the Impact of Biological Classification in Diffuse Large B Cell Lymphoma Prognosis. Analysis of Biological Markers in Patients From Clinical Trials in Geltamo and Gotel Spanish Collaborative Groups.

Santiago Montes-Moreno, Ana Batlle, MD, Sonia Gonzalez de Villambrosia, MD, Beatriz Sanchez-Espiridión, PhD, Laura Cereceda, Eva González-Barca, Purroy Noelia, MD, Emilia Pardal, Elena Sebastian, Alejandro Martin, Carlos Grande, Francisco Mazorra, MD, Andrés Insunza, Antonio Rueda, MD, Marta Llanos, MD, Jose Gomez Codina, MD, Francisco Ramon Garcia Arroyo, MD, Dolores Caballero, MD, Eulogio Conde, Andrés Lopez, MD, Mariano Provencio, Miguel Piris, MD
Journal: Blood
Blood (2012) 120 (21): 2672.
https://doi.org/10.1182/blood.V120.21.2672.2672
Published: 2012
Journal Articles

Registry of RadioImmunoTherapy: Analysis of Outcomes of Recurrent or Refractory Non-Hodgkin Lymphoma Patients Treated with 90Y Ibritumomab Tiuxetan.

Pilar Giraldo, MD, PhD, Jose Gomez Codina, MD PhD, Adriana Feixeira, MD PhD, Teresa Hernando, BS., Jose Luis Tisaire, MD PhD
Journal: Blood
Blood (2007) 110 (11): 4476.
https://doi.org/10.1182/blood.V110.11.4476.4476
Published: 2007